A detailed history of Resources Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Resources Management Corp holds 5,065 shares of AMGN stock, worth $1.49 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
5,065
Previous 4,650 8.92%
Holding current value
$1.49 Million
Previous $1.45 Million 12.32%
% of portfolio
0.22%
Previous 0.21%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$309.38 - $337.38 $128,392 - $140,012
415 Added 8.92%
5,065 $1.63 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $70,942 - $86,213
270 Added 6.16%
4,650 $1.45 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $228,539 - $275,876
850 Added 24.08%
4,380 $1.25 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $828,979 - $935,187
3,242 Added 1125.69%
3,530 $1.02 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $846,622 - $955,091
-3,311 Reduced 92.0%
288 $1.02 Million
Q3 2023

Nov 16, 2023

SELL
$218.65 - $271.46 $4,591 - $5,700
-21 Reduced 0.58%
3,599 $967,000
Q2 2023

Aug 16, 2023

SELL
$214.27 - $253.37 $2.9 Million - $3.43 Million
-13,535 Reduced 78.9%
3,620 $804,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $2.98 Million - $3.63 Million
13,188 Added 332.44%
17,155 $743,000
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $24,048 - $30,556
105 Added 2.72%
3,967 $1.04 Million
Q3 2022

Nov 15, 2022

BUY
$224.46 - $253.15 $20,201 - $22,783
90 Added 2.39%
3,862 $871,000
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $5,075 - $5,648
-22 Reduced 0.58%
3,772 $918,000
Q1 2022

May 20, 2022

SELL
$219.27 - $242.57 $35,083 - $38,811
-160 Reduced 4.05%
3,794 $918,000
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $241,440 - $276,306
-1,214 Reduced 23.49%
3,954 $890,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $319,890 - $374,790
-1,507 Reduced 22.58%
5,168 $1.1 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $322,807 - $358,131
-1,382 Reduced 17.15%
6,675 $1.63 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $57,474 - $66,977
259 Added 3.32%
8,057 $2.01 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $81,142 - $96,626
375 Added 5.05%
7,798 $1.79 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $3,519 - $3,914
-15 Reduced 0.2%
7,423 $1.89 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $9,890 - $12,137
50 Added 0.68%
7,438 $1.75 Million
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $39,728 - $52,690
218 Added 3.04%
7,388 $1.5 Million
Q3 2019

Dec 04, 2019

BUY
$174.11 - $208.62 $55,889 - $66,967
321 Added 4.69%
7,170 $1.39 Million
Q4 2018

Feb 21, 2019

SELL
$178.4 - $208.25 $3,568 - $4,165
-20 Reduced 0.29%
6,849 $1.33 Million
Q3 2018

Nov 15, 2018

BUY
$185.29 - $208.89 $1.27 Million - $1.43 Million
6,869 New
6,869 $1.42 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.